STOCK TITAN

Curaleaf (CURLF) answers latest Aurora Cannabis statement

(High)
(Neutral)
Form Type
425

Rhea-AI Filing Summary

Curaleaf Holdings, Inc. (CURLF) reports that on August 24, 2026 it issued a press release responding to a prior press release by Aurora Cannabis. The company is furnishing this press release as Exhibit 99.1 under an Item 8.01 "Other Events" current report. Curaleaf states that the information in this report, including Exhibit 99.1, is being furnished in accordance with General Instruction B.2 of Form 8-K and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference into other Securities Act or Exchange Act filings, unless specifically referenced.

Positive

  • None.

Negative

  • None.
Date of press release August 24, 2026 Date Curaleaf issued the press release furnished as Exhibit 99.1
General Instruction B.2 of Form 8-K regulatory
"In accordance with General Instruction B.2 of Form 8-K, the information"
Section 18 of the Securities Exchange Act of 1934 regulatory
"shall not be deemed to be “filed” for purposes of Section 18 of the"
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

Why did Curaleaf Holdings, Inc. (CURLF) file this Form 8-K?

Curaleaf filed this Form 8-K to report that on August 24, 2026 it issued a press release responding to Aurora Cannabis' latest press release and to furnish that Curaleaf press release as Exhibit 99.1 under Item 8.01 "Other Events."

What is included as Exhibit 99.1 in Curaleaf (CURLF)'s Form 8-K?

Exhibit 99.1 is a press release dated August 24, 2026 issued by Curaleaf Holdings, Inc. responding to Aurora Cannabis' latest press release. The Form 8-K identifies this exhibit under Item 9.01(d) as part of the furnished information.

Is Curaleaf (CURLF)'s Exhibit 99.1 considered "filed" for Exchange Act liability?

No. Curaleaf states that the information in this Form 8-K, including Exhibit 99.1, is furnished under General Instruction B.2 of Form 8-K and is not deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to that section's liability.

Can Curaleaf (CURLF)'s August 24, 2026 press release be incorporated by reference into other filings?

Curaleaf explains that the information in this Form 8-K, including the August 24, 2026 press release, will not be incorporated by reference into any registration statement or other filing under the Securities Act or Exchange Act, except where a later filing expressly incorporates it by specific reference.

What other exhibits are listed in Curaleaf (CURLF)'s Form 8-K?

In addition to the press release as Exhibit 99.1, Curaleaf lists Exhibit 104, described as the Cover Page Interactive Data File embedded within the Inline XBRL document, under Item 9.01(d) of the Form 8-K.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): August 24, 2026
CURALEAF HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
British Columbia, Canada
(State or other jurisdiction of
incorporation or organization)
333-249081
(Commission File Number)
98-1461045
(I.R.S. Employer Identification Number)
250 Harbor Drive, Third Floor, Stamford, Connecticut 06902
(Address of principal executive offices and zip code)
( 917 ) 717 - 5875
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

x
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: None.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company    ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 8.01. Other Events.
On August 24, 2026, Curaleaf Holdings, Inc. issued a press release responding to Aurora Cannabis' latest press release, a copy of which is attached as Exhibit 99.1.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number
Description
99.1
Press release dated August 24, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CURALEAF HOLDINGS, INC.
(Registrant)
Date:
August 24, 2026
By:
/s/ Peter Clateman
Name:
Peter Clateman
Title:
Chief Legal Officer